ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,167.60
      -0.71%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.775
      -0.91%
      Bitcoin
      65,940.45
      -2.46%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Vertex Pharmaceuticals Inc (VRTX)

      7. Vertex Pharmaceuticals Inc (VRTX) Financials

      Vertex Pharmaceuticals Inc

      Vertex Pharmaceuticals Inc (VRTX)

      Vortex Energy Corp
      490.32
      -5.59
      (-1.13%)
      At close: July 23 4:00PM
      Delayed by 15 minutes
      490.32
      0.07
      ( 0.01% )
      After Hours: 5:44PM
      Delayed by 15 minutes

      Vertex Pharmaceuticals Inc Financial Summary

      The current VRTX market cap is 126.53B. The company's latest EPS is USD 13.8359 and P/E is 35.44.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 2.37B2.5B2.48B2.57B2.69B
      Operating Income 777.1M1.03B1.04B988.5M1.14B
      Net Income 699.8M915.7M1.04B919.6M1.1B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 4.16B6.21B7.58B8.99B9.92B
      Operating Income 1.2B2.86B2.78B4.31B3.83B
      Net Income 1.18B2.71B2.34B3.32B3.57B

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 18.97B20.35B21.73B22.73B23.92B
      Total Liabilities 4.54B4.88B5.21B5.15B5.37B
      Total Equity 14.43B15.47B16.51B17.58B18.55B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.32B11.75B13.43B18.15B22.73B
      Total Liabilities 2.23B3.06B3.33B4.24B5.15B
      Total Equity 6.09B8.69B10.1B13.91B17.58B

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 899.9M2.03B3.3B3.54B1.31B
      Investing -1.83B-2.14B-2.26B-3.14B-2.14B
      Financing -294.7M-277.4M-442.4M-562.2M-357.5M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 1.57B3.25B2.64B4.13B3.54B
      Investing -1.24B99.39M-340.9M-321.1M-3.14B
      Financing 126.77M-505.28M-1.48B-67.7M-562.2M

      Stats and Ratios

      Market Cap 126.53B
      Price to Earnings Ratio 35.44
      Price to Sales Ratio 12.75
      Price to Cash Ratio 12.2
      Price to Book Ratio 7.2
      Dividend Yield -

      Share Statistics

      Shares Outstanding 258.05M
      Average Volume (1 week) 1.33M
      Average Volume (1 Month) 1.02M
      52 Week Change 35.51%
      52 Week High 498.77
      52 Week Low 340.20
      Spread (Intraday) 5.51 (1.11%)

      Company Info

      Company Name Vertex Pharmaceuticals Inc
      Address 50 northern avenue
      boston, massachusetts 02210
      Website https://www.vrtx.com
      Industry pharmaceutical preparations (2834)